IDx is transforming healthcare with autonomous AI systems that enable a specialist diagnosis on the frontlines of care.


Founded 2010
Invested 2018

Michael Abramoff

Related Article
The FDA just opened the door to let AI make medical decisions on its own

View All


IDx is a leading AI diagnostics company on a mission to transform the quality, accessibility, and affordability of healthcare. Founded in 2010 by a team of world-renowned clinician scientists, the company is focused on developing clinically-aligned autonomous algorithms that detect disease in medical images.

By enabling diagnostic assessment in primary care settings, IDx aims to increase patient access to high-quality, affordable disease detection.

The company’s first product, IDx-DR, is the first and only FDA-cleared AI-based diagnostic system for the autonomous detection of diabetic retinopathy.




© 2016-2018 Alpha Edison. All rights reserved.